Weighted Kaplan-Meier estimators for two-stage treatment regimes

Statistics in Medicine

Volumn 29, Issue 25, 2010, Pages 2581-2591

  Miyahara, Sachiko ^a   Wahed, Abdus S ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adaptive treatment strategies; Inverse probability weighting; Kaplan Meier estimator; Survival analysis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLACEBO;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; HUMAN; KAPLAN MEIER METHOD; MAINTENANCE THERAPY; PROBABILITY; RANDOMIZATION; RISK ASSESSMENT; SIMULATION; SURVIVAL; TREATMENT INDICATION; TREATMENT RESPONSE;

COMPUTER SIMULATION; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 77958531196     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4020     Document Type: Article

References (14)

1. Lavori PW, Dawson R. A design of for testing clinical strategies: biased individually tailored within-subject randomization. Journal of the Royal Statistical Society 2000; 163:29-38.
2. Wolbers M, Helterbrand JD. Two-stage randomization designs in drug development. Statistics in Medicine 2008; 27:4161-4174.
3. Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA. Granulocytemacrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. New England Journal of Medicine 1995; 332:1671-1677.
4. Murphy SA, Van Der Laan MJ, Robins JM. Marginal mean models for dynamic regimes. Journal of American Statistical Association 2001; 96:1410-1423.
5. Lunceford JK, Davidian M, Tsiatis AA. Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics 2002; 58:48-57.
6. Guo X, Tsiatis AA. A weighted risk set estimator for survival distributions in two-stage randomization designs with censored survival data. International Journal of Biostatistics 2005; 1:1-15.
7. Robins JM, Rotnitzky A, Zhao LP. Estimation of regression coefficients when some regressors are not always observed. Journal of the American Statistical Association 1994; 89:846-866.
8. Aalen OO. Nonparametric inference for a family of counting processes. Annals of Statistics 1978; 6:701-726.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 95:695-707.
10. Wahed AS, Tsiatis AA. Semi-parametric efficient estimation of the survival distribution for two-stage randomization designs in clinical trials with censored data. Biometrika 2006; 93:147-161.
11. Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Statistics in Medicine 2005; 24:3089-3110.
12. Greenwood M. The natural duration of cancer. Reports on public health and medical subjects. London: Her Majesty's Stationery Office 1926; 33:1-26.
13. Efron BF, Tibshirani RJ. An Introduction to the Bootstrap. Chapman & Hall: London, 1993.
14. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Medical Care 2007; 45(10):103-107.